Several decades years ago, Swan F, Jr.29 questioned Ann Arbor staging system and insisted that the serum levels of β2-M might provide a more precise system for defining risk groups in large-cell lymphomas. The gene discussed is B2M; the disease is anaplastic large cell lymphoma.